Tim Wiltshire - Search Results

Year	Number of Results
2002	1
2003	2
2004	5
2005	6
2006	7
2007	4
2008	6
2009	5
2010	7
2011	4
2012	5
2013	4
2014	3
2015	4
2016	3
2017	5
2018	8
2019	4
2020	3
2021	3
2022	3
2023	3
2024	1

1

Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model.

Karas S, Mathijssen RHJ, van Schaik RHN, Forrest A, Wiltshire T, Bies RR, Innocenti F. Karas S, et al. Among authors: wiltshire t. Clin Pharmacol Ther. 2024 May;115(5):1162-1174. doi: 10.1002/cpt.3190. Epub 2024 Feb 12. Clin Pharmacol Ther. 2024. PMID: 38344867

2

Pharmacogenomic Analyses Implicate B Cell Developmental Status and MKL1 as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy.

Small GW, Akhtari FS, Green AJ, Havener TM, Sikes M, Quintanhila J, Gonzalez RD, Reif DM, Motsinger-Reif AA, McLeod HL, Wiltshire T. Small GW, et al. Among authors: wiltshire t. Cells. 2023 Jun 7;12(12):1574. doi: 10.3390/cells12121574. Cells. 2023. PMID: 37371044 Free PMC article.

3

MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients.

Gonzalez RD, Small GW, Green AJ, Akhtari FS, Motsinger-Reif AA, Quintanilha JCF, Havener TM, Reif DM, McLeod HL, Wiltshire T. Gonzalez RD, et al. Among authors: wiltshire t. Pharmaceuticals (Basel). 2023 May 17;16(5):757. doi: 10.3390/ph16050757. Pharmaceuticals (Basel). 2023. PMID: 37242540 Free PMC article.

4

RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients.

Gonzalez RD, Small GW, Green AJ, Akhtari FS, Havener TM, Quintanilha JCF, Cipriani AB, Reif DM, McLeod HL, Motsinger-Reif AA, Wiltshire T. Gonzalez RD, et al. Among authors: wiltshire t. Pharmaceuticals (Basel). 2023 May 10;16(5):726. doi: 10.3390/ph16050726. Pharmaceuticals (Basel). 2023. PMID: 37242509 Free PMC article.

5

Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Advanced Cancer Patients: Influence of Demographic and Clinical Factors.

Karas S, Mathijssen RHJ, van Schaik RHN, Forrest A, Wiltshire T, Innocenti F, Bies RR. Karas S, et al. Among authors: wiltshire t. Clin Pharmacol Ther. 2022 Aug;112(2):316-326. doi: 10.1002/cpt.2621. Epub 2022 May 18. Clin Pharmacol Ther. 2022. PMID: 35467016 Free PMC article.

6

The feasibility and potential of pharmacogenetics to reduce adverse drug events in nursing home residents.

Kistler CE, Austin CA, Liu JJ, Cauble M, Wise A, Patel SM, Ward K, Wiltshire T, Zou F, Szeto AH, Crona DJ. Kistler CE, et al. Among authors: wiltshire t. J Am Geriatr Soc. 2022 May;70(5):1573-1578. doi: 10.1111/jgs.17679. Epub 2022 Feb 14. J Am Geriatr Soc. 2022. PMID: 35157308 Free PMC article. No abstract available.

7

Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID-19 pandemic.

Zhu J, Rao G, Armistead PM, Ptachcinski J, Weiner DL, Wiltshire T, Crona DJ. Zhu J, et al. Among authors: wiltshire t. Clin Transl Sci. 2022 Mar;15(3):583-587. doi: 10.1111/cts.13177. Epub 2021 Nov 7. Clin Transl Sci. 2022. PMID: 34743423 Free PMC article. No abstract available.

8

Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients.

Zhu J, Campagne O, Torrice CD, Flynn G, Miller JA, Patel T, Suzuki O, Ptachcinski JR, Armistead PM, Wiltshire T, Mager DE, Weiner DL, Crona DJ. Zhu J, et al. Among authors: wiltshire t. Clin Transl Sci. 2021 May;14(3):908-918. doi: 10.1111/cts.12956. Epub 2021 Jan 27. Clin Transl Sci. 2021. PMID: 33502111 Free PMC article. Clinical Trial.

9

North Carolina's multi-institutional pharmacogenomics efforts with the North Carolina Precision Health Collaborative.

Patel JN, Voora D, Bell G, Bates J, Cipriani A, Bendz L, Frick A, Hamadeh I, McGee AS, Steuerwald N, Imhof S, Wiltshire T. Patel JN, et al. Among authors: wiltshire t. Pharmacogenomics. 2021 Jan;22(2):73-80. doi: 10.2217/pgs-2020-0156. Epub 2021 Jan 15. Pharmacogenomics. 2021. PMID: 33448876

10

Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients.

Black RM, Williams AK, Ratner L, Crona DJ, Wiltshire T, Weck KE, Stouffer GA, Lee CR. Black RM, et al. Among authors: wiltshire t. Pharmacogenomics. 2020 May;21(7):431-441. doi: 10.2217/pgs-2019-0185. Epub 2020 Apr 28. Pharmacogenomics. 2020. PMID: 32343201 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year